Table 2. Survivor Treatment and Health Demographic Statistics.
| Survivors | FACIT | PSQI | ESS | |||||
|---|---|---|---|---|---|---|---|---|
| N=751 | ≤30 | >30 | >5 | ≤5 | ≥10 | 10 | ||
| N | % | N (row %) | N (row %) | N (row %) | N (row %) | N (row %) | N (row %) | |
| Radiation Therapy | ||||||||
| Chest RT<30Gy | 230 | 30.6 | 36 (15.7) | 194 (84.3) | 116 (50.4) | 114 (49.6) | 45 (19.6) | 185 (80.4) |
| Chest RT≥30Gy | 445 | 59.3 | 80 (18.0) | 365 (82.0) | 249 (56.0) | 196 (44.0) | 98 (22.0) | 347 (78.0) |
| Chemotherapy* | ||||||||
| Anthracycline | 158 | 21.0 | 27 (17.1) | 131 (82.9) | 86 (54.4) | 72 (45.6) | 32 (20.3) | 126 (79.7) |
| Alkylating Agents | 419 | 55.8 | 70 (16.7) | 349 (83.3) | 228 (54.4) | 191 (45.6) | 93 (22.2) | 326 (77.8) |
| Bleomycin | 147 | 19.6 | 24 (16.3) | 123 (83.7) | 83 (56.5) | 64 (43.5) | 34 (23.1) | 113 (76.9) |
| Vinca Alkaloids & Heavy Metals | 418 | 55.7 | 71 (17.0) | 347 (83.0) | 230 (55.0) | 188 (45.0) | 94 (22.5) | 324 (77.5) |
| None | 326 | 43.4 | 57 (17.5) | 269 (82.5) | 174 (53.4) | 152 (46.6) | 71 (21.8) | 255 (78.2) |
| Cancer related pain | ||||||||
| None/Small amount | 682 | 90.8 | 88 (12.9) | 594 (87.1) | 344 (50.4) | 338 (49.6) | 143 (21.0) | 539 (79.0) |
| Medium/A lot/Very bad | 69 | 9.2 | 40 (58.0) | 29 (42.0) | 62 (89.9) | 7 (10.1) | 22 (31.9) | 47 (68.1) |
| Body Mass Index | ||||||||
| Normal | 355 | 47.3 | 55 (15.5) | 300 (84.5) | 194 (54.6) | 161 (45.4) | 54 (15.2) | 301 (84.8) |
| Overweight | 246 | 32.8 | 41 (16.7) | 205 (83.3) | 128 (52.0) | 118 (48.0) | 64 (26.0) | 182 (74.0) |
| Obese | 131 | 17.4 | 27 (20.6) | 104 (79.4) | 76 (58.0) | 55 (42.0) | 46 (35.1) | 85 (64.9) |
*
Patients may receive multi chemotherapy so the percentage exceeds 100